Beaton Management Co. Inc. Abb Vie Inc. Transaction History

Beaton Management Co. Inc.

$198 Million
Q3 2024

A detailed history of Beaton Management Co. Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Beaton Management Co. Inc. holds 10,434 shares of ABBV stock, worth $1.79 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

10,434

Previous 10,933 4.56%

Holding current value

$1.79 Million

Previous $1.88 Million 9.92%

% of portfolio

1.04%

Previous 1.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$163.84 - $199.33 $81,756 - $99,465	-499 Reduced 4.56%	10,434 $2.06 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $7,429 - $8,676	48 Added 0.44%	10,933 $1.88 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $8,310 - $9,469	52 Added 0.48%	10,885 $1.98 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $8,944 - $10,073	-65 Reduced 0.6%	10,833 $1.68 Million
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $5,477 - $6,340	41 Added 0.38%	10,898 $1.63 Million
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $31,537 - $39,246	238 Added 2.24%	10,857 $1.46 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $14,316 - $16,487	-99 Reduced 0.92%	10,619 $1.69 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $276 - $331	2 Added 0.02%	10,718 $1.73 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $16,642 - $19,087	-124 Reduced 1.14%	10,716 $1.44 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $22,569 - $28,693	-164 Reduced 1.49%	10,840 $1.66 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $395 - $491	3 Added 0.03%	11,004 $1.78 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $10,640 - $12,078	100 Added 0.92%	11,001 $1.19 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $21,042 - $23,442	-200 Reduced 1.8%	10,901 $1.23 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $181,480 - $199,787	1,774 Added 19.02%	11,101 $1.2 Million
Q4 2020 Feb 17, 2021	BUY	$80.49 - $108.67 $8,048 - $10,867	100 Added 1.08%	9,327 $999,000
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $45,961 - $53,944	-535 Reduced 5.48%	9,227 $808,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $130,378 - $174,465	1,777 Added 22.25%	9,762 $958,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $20,962 - $31,781	325 Added 4.24%	7,985 $608,000
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $21,639 - $27,075	300 Added 4.08%	7,660 $678,000
Q3 2019 Nov 15, 2019	BUY	$62.98 - $75.72 $12,596 - $15,144	200 Added 2.79%	7,360 $557,000
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $16,425 - $20,995	250 Added 3.62%	7,160 $521,000
Q4 2017 Feb 07, 2018	SELL	$89.56 - $98.21 $32,778 - $35,944	-366 Reduced 5.03%	6,910 $668,000
Q2 2017 Aug 17, 2017	BUY	N/A	7,276	7,276 $528,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaton Management Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beaton Management Co. Inc. with notifications on news.

Account

Beaton Management Co. Inc. Abb Vie Inc. Transaction History